The treatment
Injection-only treatment, arthroscopy and joint replacement create very different recovery and clot-risk profiles.
International & VIP patients
Flying home after orthopaedic treatment
Your return journey is planned around the treatment, your mobility and your individual blood-clot risk. It is never treated as an automatic part of the pathway.
Read the International Patient Guide
Reviewed byProfessor Paul Lee MBBch, FRCS (Tr & Orth), PhDCartilage and joint preservation expertiseThere is no universal waiting period
The practical issue is prolonged immobility, not the aircraft alone
Less invasive treatment often means quicker recovery and earlier movement than open surgery. That helps, but it does not make a flight automatically safe. We plan the journey around what was done, how freely you can move, how long you will be seated and the factors that change your own risk of a blood clot.
Your mobility
We need to know that you can move safely, manage the airport and change position during the journey.
Journey length
A short flight and a long-haul journey are not treated as the same exposure to prolonged immobility.
Your individual risk
Previous clots, age, health, medication and the procedure all affect the plan and timing.
Keyhole and minimally invasive treatment
Earlier movement helps, but the full journey still matters
Many overseas patients travel specifically for image-guided injections and minimally invasive interventions that are not available at home. These treatments usually cause less tissue disruption and allow earlier mobilisation than traditional open surgery.
NanoACi is a non-arthroscopic RegenRepair™ pathway delivered by image-guided injection. It leaves no surgical wound or visible dressing, but we still assess walking, weight-bearing, pain control, the duration of the journey and personal VTE risk before agreeing a return plan.
Space helps; cabin class is not protection
Many of our international patients choose business or first class. The extra room can make it easier to change position, reach the aisle and remain comfortable. Those advantages are useful, but the cabin class itself does not prevent a clot and never replaces walking, calf exercises or prescribed prophylaxis.
Hip and knee replacement
Major surgery needs a different level of caution
Joint replacement carries a higher postoperative risk of deep-vein thrombosis and pulmonary embolism, regardless of whether general or regional anaesthesia is used.
Published studies of selected patients who flew after hip or knee replacement have generally reported low absolute complication rates when early mobilisation, mechanical measures and appropriate anticoagulant prophylaxis were used. The evidence is observational, however, and does not establish one universally safe day to fly. Every return journey is assessed individually.
How we reduce travel-related risk
A plan matched to the procedure and the patient
- Early mobilisation and regular in-seat calf and ankle exercises.
- Properly fitted graduated compression stockings when clinically appropriate.
- An aisle seat and periodic walking when permitted.
- A procedure-specific course of postoperative blood-clot prophylaxis.
- For selected higher-risk patients on journeys longer than four hours, prescription anticoagulant prophylaxis timed around travel.
- Coordination with the airline where medical clearance, mobility assistance or supplementary oxygen is required.
Blood thinners require clinical judgement
Anticoagulant medication can reduce clot risk, but it can also cause bleeding. It must be prescribed for the individual patient and coordinated with any existing postoperative medication.
Never add aspirin, increase an anticoagulant dose or use somebody else’s medication before a flight.
When flying should be delayed
New or worsening symptoms need review before travel
Increasing wound pain, redness or discharge
Fever or suspected infection
Uncontrolled pain or vomiting
Significant anaemia or unexpected weakness
New breathlessness or chest pain
One-sided calf swelling or pain
Mobility that is not adequate for the journey
Your surgeon’s clinical clearance and the airline’s permission are separate requirements. The airline retains the final decision about whether a passenger can travel.
What the evidence says
Reassuring in places, but not strong enough for a universal rule
The most useful reading of the evidence is not “flying is safe” or “flying is unsafe”. It is that absolute event rates can be low in selected patients following a managed pathway, while uncertainty and conflicting findings make individual assessment essential.
| Evidence | Finding | Important limitation |
|---|---|---|
| 2025 systematic review and meta-analysis | Seven studies and 24,975 patients. Postoperative flying was not associated with a statistically significant additional VTE risk: OR 1.31 (95% CI 0.63–2.71). The high-risk surgery subgroup was also non-significant: OR 1.20 (95% CI 0.45–3.20). | Every included study was retrospective. The wide confidence intervals cannot rule out a clinically important increase in risk. |
| Cooper et al., 2014 | Among 1,465 hip and knee replacement patients, 220 flew home an average of 2.9 days after surgery. DVT, PE and overall VTE rates did not differ from non-flyers. | This was a selected cohort following one clinical pathway, with risk-stratified mechanical and drug prophylaxis. |
| Mahmood et al., 2023 | A conflicting UK study found VTE in 4 of 243 air travellers and 32 of 5,498 land travellers: about 1.65% versus 0.58%, relative risk 2.85. The mean flight was 74 minutes. | Retrospective, with only four events in the flying group, but an important warning against claiming zero additional risk. |
| Review of UK advice after joint replacement | Surgeons’ recommendations ranged from 14 to 180 days. Median advice was 45 days for short-haul and 90 days for long-haul travel in patients without additional risk factors. | This demonstrates the absence of a settled evidence-based waiting period; it does not prove those particular intervals are safe for everyone. |
Clinical guidance used alongside the evidence
The pathway also considers current NICE guidance on VTE risk assessment and prophylaxis and Civil Aviation Authority guidance for health professionals. These sources support procedure-specific assessment rather than one rule for every patient.
Planning the journey home
Questions about flying after treatment
How soon can I fly after NanoACi?
There is no standard number of days that is safe for everyone. NanoACi is an image-guided, non-arthroscopic treatment with no surgical wound, but timing still depends on your mobility, the length of the flight and your personal blood-clot risk. Your return journey is agreed as part of your treatment plan.
Is business or first class safer after treatment?
A more spacious seat may make it easier to change position, elevate the leg when appropriate and reach the aisle. Cabin class does not remove blood-clot risk, however, and never replaces movement, exercises or prescribed prophylaxis.
Will I need blood-thinning medication for the flight?
Only if it is appropriate for your procedure and individual risk. Blood thinners can also cause bleeding, so they must be prescribed and coordinated with your existing postoperative medication. Never add aspirin, change a dose or use somebody else’s medication for a flight.
Does a small incision or injection-only treatment mean flying is risk-free?
No. Less invasive treatment usually allows earlier mobilisation, but the journey still involves periods of reduced movement. Procedure type, mobility, flight duration and personal risk are assessed together.
Is my surgeon’s clearance enough for the airline?
No. Clinical clearance and the airline’s permission are separate requirements. The airline may ask for its own medical form, impose different timing rules or make the final decision that a passenger cannot travel.
This page describes our approach to travel planning. It is not a personal fitness-to-fly assessment, a prescription or a guarantee that an airline will accept a passenger.
Plan the treatment and the journey together
Before you book travel, talk to the team about the proposed treatment, your route home and the support you may need.